Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Doxycycline for Hereditary Hemorrhagic Telangiectasia (HHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03397004
Recruitment Status : Recruiting
First Posted : January 11, 2018
Last Update Posted : January 11, 2019
Sponsor:
Collaborators:
Barrow Neurological Institute
Duke University
Feinstein Institute for Medical Research
University of Pittsburgh
Sunnybrook Health Sciences Centre
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2020
  Estimated Study Completion Date : December 2020